NASDAQ:ACRS

Aclaris Therapeutics Stock Insider Trading

Healthcare > Medical - Diagnostics & Research

Buy ACRS

*Your capital is at risk

$5.20

-0.120 (-2.26%)

At Close: Jul 31, 2026

Aclaris Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 35.04. In total, the insiders bought 6.24M and sold 449.42K ACRS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	35.04
● Buy	6.24M shares
● Sell	449.42K shares
85% Buy Activity Strong Negative Correlation
Sell Signal Low Confidence Apr 23, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 35.04. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jan 01, 2026 Buy	Common Stock M-Exempt	Balthaser Kevin Chief Financial Officer	C-Suite Officer	7 500 Value: $39.0K
Dec 31, 2025 Buy	Restricted Stock Units M-Exempt	Balthaser Kevin Chief Financial Officer	C-Suite Officer	73 750 Value: $222.0K
Dec 31, 2025 Sell	Common Stock F-InKind	Balthaser Kevin Chief Financial Officer	C-Suite Officer	19 934 Value: $60.0K
Dec 31, 2025 Buy	Common Stock M-Exempt	Loerop James Chief Business Officer	Officer	73 750 Value: $222.0K
Dec 31, 2025 Sell	Common Stock F-InKind	Loerop James Chief Business Officer	Officer	33 994 Value: $102.3K
Dec 31, 2025 Buy	Restricted Stock Units M-Exempt	Loerop James Chief Business Officer	Officer	73 750 Value: $222.0K
Dec 31, 2025 Buy	Common Stock M-Exempt	Balthaser Kevin Chief Financial Officer	C-Suite Officer	73 750 Value: $222.0K
Dec 02, 2025 Buy	Restricted Stock Units M-Exempt	Davis Hugh M. President And COO	CEO / President	26 750 Value: $72.2K
Dec 02, 2025 Buy	Common Stock M-Exempt	Davis Hugh M. President And COO	CEO / President	26 750 Value: $72.2K
Aug 01, 2025 Buy	Employee Stock Option (right to buy) A-Award	Kolbeck Roland Wilhelm Chief Scientific Officer	Officer	510 000 Value: $780.3K
Aug 01, 2025 Buy	Restricted Stock Units A-Award	Kolbeck Roland Wilhelm Chief Scientific Officer	Officer	145 500 Value: $222.6K
Aug 01, 2025 Buy	Restricted Stock Units A-Award	Kolbeck Roland Wilhelm Chief Scientific Officer	Officer	145 500 Value: $222.6K
Aug 01, 2025 Buy	Employee Stock Option (right to buy) A-Award	Kolbeck Roland Wilhelm Chief Scientific Officer	Officer	510 000 Value: $780.3K
Jul 28, 2025 Buy	Common Stock J-Other	Kolbeck Roland Wilhelm Insider	Other	0 Value: $0
Jul 28, 2025 Buy	Common Stock J-Other	Kolbeck Roland Wilhelm Insider	Other	0 Value: $0
Jun 06, 2025 Buy	Common Stock M-Exempt	Mehra Anand Director	Director	4 793 Value: $7K
Jun 06, 2025 Buy	Restricted Stock Units M-Exempt	Milano Vincent Director	Director	4 793 Value: $7K
Jun 06, 2025 Buy	Common Stock M-Exempt	Milano Vincent Director	Director	4 793 Value: $7K
Jun 06, 2025 Buy	Restricted Stock Units M-Exempt	Schiff Andrew N Director	Director	4 793 Value: $7K
Jun 06, 2025 Buy	Common Stock M-Exempt	Schiff Andrew N Director	Director	4 793 Value: $7K
Jun 05, 2025 Buy	Stock Option (Right to Buy) A-Award	Mehra Anand Director	Director	42 350 Value: $66.1K
Jun 05, 2025 Buy	Restricted Stock Units A-Award	Milano Vincent Director	Director	11 580 Value: $18.1K
Jun 05, 2025 Buy	Stock Option (Right to Buy) A-Award	Milano Vincent Director	Director	42 350 Value: $66.1K
Jun 05, 2025 Buy	Restricted Stock Units A-Award	Schiff Andrew N Director	Director	11 580 Value: $18.1K
Feb 01, 2025 Sell	Common Stock F-InKind	Loerop James Chief Business Officer	Officer	15 980 Value: $39.6K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks